← Back to Patent Explorer
US6059772A Expired / Lapsed US ⏱️ 0.0 years remaining

Apparatus and method for treating glaucoma using a gonioscopic laser trabecular ablation procedure

Assignee: Candela Corp
•
Filing: 1997-01-08
•
Granted: 2000-05-09
•
Expires: 2017-01-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A non-invasive apparatus and method for treating open angle glaucoma in a human eye comprises thermally ablating a targeted region of the trabecular meshwork of a human eye by irradiating the region with a beam of pulsed laser radiation. The beam of pulsed radiation has a wavelength between 350 and 1300 nanometers, energy of 10 to 500 millijoules per pulse, and pulse duration of 0.1 to 50 microseconds. The beam is non-invasively delivered gonioscopically through the cornea onto a targeted region of the trabecular meshwork. The targeted region of the trabecular meshwork is illuminated at a spot size of between 50 and 300 microns in diameter.

Inventors

  • 👤 James C. Hsia
  • 👤 Shlomo Melamed
  • 👤 Joseph A. Lowery

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:36
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/008; A61F9/00802; A61F9/00821; A61F9/009; A61B; A61B17/00; A61B2017/00017; A61B2017/00137; A61B2017/00154; A61B2017/00181; A61B2017/00194; A61F2009/00861; A61F2009/00868; A61F2009/00885; A61F2009/00891

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 89 words
A non-invasive method of treating glaucoma in a human eye, the method comprising the steps of: delivering a beam of pulsed laser radiation of wavelength betwveen 350 and 1300 nanometers, energy of 10 to 500 millijoules per pulse, pulse duration of 0.1 to 50 microseconds and spot size of up to 300 microns in diameter to a region of trabecular meshwork within a human eye; thermally ablating the region with the beam of pulsed laser radiation to reduce intraocular pressure while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 2
Dependent Claim 89 words
A non-invasive method of treating glaucoma in a human eye, the method comprising the steps of: delivering a beam of pulsed laser radiation of wavelength betwveen 350 and 1300 nanometers, energy of 10 to 500 millijoules per pulse, pulse duration of 0.1 to 50 microseconds and spot size of up to 300 microns in diameter to a region of trabecular meshwork within a human eye; thermally ablating the region with the beam of pulsed laser radiation to reduce intraocular pressure while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 3
Dependent Claim 15 words
The method of claim 1 further comprising delivering the beam of pulsed laser radiation gonioscopically.
Claim 4
Dependent Claim 27 words
The method of claim 1 wherein the delivering step further comprises delivering a beam of pulsed laser radiation having a pulse duration of 1 to 50 microseconds.
Claim 5
Dependent Claim 26 words
The method of claim 1 wherein the delivering step further comprises delivering a beam of pulsed laser raditation having a wavelength between 700 and 900 nanometers.
Claim 6
Dependent Claim 28 words
The method of claim 1 wherein the delivering step further comprises delivering a beam of pulsed laser radiation having a per pulse energy of 25 to 250 millijoules.
Claim 7
Dependent Claim 31 words
The method of claim 1 wherein the delivering step further comprises delivering a beam of pulsed beam of laser radiation having a spot size of 50 to 300 microns in diameter.
Claim 8
Dependent Claim 108 words
A non-invasive method of treating glaucoma in a human eye, the method comprising the steps of: generating a beam of pulsed laser radiation of wavelength between 350 and 1300 nanometers, energy of 10 to 500 millijoules per pulse, pulse duration of 0.1 to 50 microseconds, and spot -- size of up to 200 microns in diameter using a solid state laser; delivering the beam of pulsed laser radiation to a region of trabecular meshwork within a human eye; thermally ablating material disposed between meshwork fibers of the region with the beam of pulsed laser radiation to reduce intraocular pressure while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 9
Dependent Claim 108 words
A non-invasive method of treating glaucoma in a human eye, the method comprising the steps of: generating a beam of pulsed laser radiation of wavelength between 350 and 1300 nanometers, energy of 10 to 500 millijoules per pulse, pulse duration of 0.1 to 50 microseconds, and spot -- size of up to 200 microns in diameter using a solid state laser; delivering the beam of pulsed laser radiation to a region of trabecular meshwork within a human eye; thermally ablating material disposed between meshwork fibers of the region with the beam of pulsed laser radiation to reduce intraocular pressure while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 10
Dependent Claim 103 words
A non-invasive method of treating open angle glaucoma in a human eye, the method comprising the steps of: generating a beam of pulsed laser radiation of wavelength between 700 and 900 nanometers, energy of 25 to 500 millijoules per pulse, spot -- size of 50 to 300 microns in diameter and pulse duration of 1 to 50 microseconds using a Ti:Sapphire laser; delivering the beam of pulsed laser radiation gonioscopically to a targeted region of trabecular meshwork within a human eye; and thermally ablating the targeted region with the beam of pulsed laser radiation while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 11
Dependent Claim 103 words
A non-invasive method of treating open angle glaucoma in a human eye, the method comprising the steps of: generating a beam of pulsed laser radiation of wavelength between 700 and 900 nanometers, energy of 25 to 500 millijoules per pulse, spot -- size of 50 to 300 microns in diameter and pulse duration of 1 to 50 microseconds using a Ti:Sapphire laser; delivering the beam of pulsed laser radiation gonioscopically to a targeted region of trabecular meshwork within a human eye; and thermally ablating the targeted region with the beam of pulsed laser radiation while minimizing damage to tissue surrounding the trabecular meshwork.
Claim 12
Dependent Claim 28 words
The method of claim 8 wherein the generating step further comprises generating a beam of pulsed laser radiation having a spotsize of 100 to 200 microns in diameter.
Claim 13
Dependent Claim 25 words
The method of claim 8 further comprising thermally ablating material disposed between meshwork fibers within the targeted region with the beam of pulsed laser radiation.

References Cited (Backward Citations)

US3828788A Cited
US4791927A Cited
WO1990011054A1 Cited
US5549596A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-05-09 2003-11-08 2004-05-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-05-09 2007-11-08 2008-05-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-05-09 2011-11-08 2012-05-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag